Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.90
-0.03 (-0.42%)
Jul 14, 2026, 10:29 AM EDT - Market open
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $101.27 million as of July 14, 2026. Its market cap has increased by 82.47% in one year.
Market Cap
101.27M
Enterprise Value
82.54M
1-Year Change
82.47%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.60M to $101.27M, a decrease of -76.81%. That is a compound annual growth rate of -16.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 107.50M | 36.25% |
| Dec 31, 2025 | 78.90M | 147.34% |
| Dec 31, 2024 | 31.90M | -89.64% |
| Dec 29, 2023 | 307.90M | 172.48% |
| Dec 30, 2022 | 113.00M | -55.18% |
| Dec 31, 2021 | 252.10M | -15.32% |
| Dec 31, 2020 | 297.70M | -27.32% |
| Dec 31, 2019 | 409.60M | 95.61% |
| Dec 31, 2018 | 209.40M | -52.04% |
| Jun 15, 2018 | 436.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 117.28M |
| NeOnc Technologies Holdings | 116.44M |
| Polaryx Therapeutics | 110.31M |
| Enlivex | 110.24M |
| Fortress Biotech | 109.62M |
| Black Diamond Therapeutics | 109.45M |
| Oncolytics Biotech | 105.90M |
| Kalaris Therapeutics | 105.64M |